Evofem Biosciences receives US patent covering Phexxi composition of matter
26 Sep 2022 //
PHARMABIZ
Large Commercial Payer Adds Phexxi® to Formulary for Standard Plans Nationwide
16 Sep 2022 //
PRNEWSWIRE
Evofem’s Phase III trial reveals fewer UTIs in women using Phexxi
09 May 2022 //
PHARMAFILE
Evofem Bio Announces Record Net Sales and Phexxi Prescriptions in Q4 2021
19 Jan 2022 //
PRNEWSWIRE
Formulation of Aqueous Core Poly(lactic acid) Microcapsules
08 Dec 2021 //
RODPUB
"House Rules" Delivers Strong Initial Results and Drives Phexxi Growth
20 Oct 2021 //
PRNEWSWIRE
Rising Demand For Lactic Acid From Cosmetics And Pharmaceutical Industry
30 Sep 2021 //
PRNEWSWIRE
3D-Printable Biomaterial Takes Shape for Tissue Scaffolds
20 Aug 2021 //
MDDIONLINE
Ilya’s Pharma to Present ILP100 Accelerated Wound Healing Gene Therapy
23 Jun 2021 //
CISION
Formulation of Aqueous Core Poly(lactic acid) Microcapsules
14 Jun 2021 //
CONTRACTPHARMA
Evofem Announces Launch of Phexx, First Non-Hormonal Contraceptive Vaginal Gel
10 Sep 2020 //
PRNEWSWIRE
Evofem Announces Launch of Phexx,First Non-Hormonal Contraceptive Vaginal Gel
08 Sep 2020 //
PRNEWSWIRE
U.S. FDA Approves Evofem Biosciences` Phexxi™
22 May 2020 //
PRNEWSWIRE
Enforcement Report - Week of March 22, 2017
22 Mar 2017 //
FDA
Lactic Acid Market Worth $3.82Bn & Polylactic Acid Market Worth $5.16Bn by 2020
03 Dec 2015 //
PR NEWS WIRE
Dutch firm Corbion buys lactic acid business of Malladi Specialties
23 Sep 2015 //
BUSINESS-STANDARD